Sanobiotec BIO - Company finances
|
EUR
|
2020
From: 2020-01-20
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | - | - | - | - | - | - |
| Profit before tax | - | - | -102,092 | -36,319 | -19,364 | -9,163 |
| Net profit | -48,136 | -74,699 | -102,092 | -36,319 | -19,364 | -9,163 |
| Equity | -45,636 | -120,335 | -222,427 | 2,289 | -17,074 | -307 |
| Liabilities | 87,976 | 177,790 | 257,203 | 29,234 | 20,152 | 307 |
| Non-current assets | 9,376 | 9,376 | 9,376 | 0 | 0 | 0 |
| Current assets | 32,964 | 48,079 | 25,400 | 31,523 | 3,078 | 0 |
| Total assets | 42,340 | 57,455 | 34,776 | 31,523 | 3,078 | 0 |
|
Financial indicators
|
||||||
| Revenue change y/y | - | - | - | - | - | - |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -113.7% | -130.0% | -293.6% | -115.2% | -629.1% | - |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | -1586.7% | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | - | - | - | - |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | 12.8 | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Sanobiotec BIO - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-01 | 2026-07-31 | 10.00 |
| 2026-05-03 | 2026-06-30 | 231.55 |
| 2026-04-27 | 2026-04-30 | 231.55 |
| 2026-04-26 | 2026-04-26 | 226.66 |
| 2026-04-24 | 2026-04-25 | 231.55 |
| 2026-01-22 | 2026-04-23 | 226.66 |
| 2025-10-23 | 2026-01-21 | 221.55 |
| 2025-10-16 | 2025-10-22 | 213.74 |
| 2025-09-16 | 2025-09-29 | 668.04 |
| 2025-09-07 | 2025-09-15 | 446.41 |
| 2025-08-31 | 2025-09-03 | 446.41 |
| 2025-08-19 | 2025-08-29 | 446.41 |
| 2025-07-24 | 2025-08-18 | 224.57 |
| 2025-07-16 | 2025-07-23 | 221.63 |
| 2025-07-02 | 2025-07-02 | 218.45 |
| 2025-06-17 | 2025-07-01 | 221.63 |
| 2025-05-19 | 2025-05-19 | 221.84 |
| 2025-05-16 | 2025-05-18 | 353.33 |
| 2025-05-04 | 2025-05-15 | 131.49 |
| 2025-04-30 | 2025-04-30 | 221.63 |
| 2025-04-24 | 2025-04-29 | 222.37 |
| 2025-04-16 | 2025-04-23 | 221.63 |
| 2025-03-03 | 2025-03-03 | 115.75 |
| 2025-02-18 | 2025-02-26 | 115.75 |
| 2025-02-10 | 2025-02-10 | 1.66 |
| 2025-01-23 | 2025-02-05 | 1.66 |
| 2025-01-22 | 2025-01-22 | 198.74 |
| 2025-01-16 | 2025-01-21 | 197.08 |
| 2025-01-02 | 2025-01-12 | 197.25 |
| 2024-12-22 | 2024-12-31 | 197.25 |
| 2024-12-17 | 2024-12-20 | 197.25 |
| 2024-10-16 | 2024-10-17 | 197.25 |
| 2024-08-19 | 2024-09-15 | 0.11 |
| 2024-07-24 | 2024-08-13 | 0.11 |
| 2024-05-16 | 2024-05-16 | 197.25 |
| 2024-01-23 | 2024-02-14 | 0.75 |
| 2023-12-18 | 2023-12-28 | 179.38 |
| 2022-08-10 | 2022-08-10 | 0.68 |
| 2022-04-19 | 2022-04-20 | 375.79 |
Sanobiotec BIO - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-07-02 | 2026-07-07 | 1.71 |
| 2026-06-14 | 2026-07-01 | 39.78 |
| 2026-06-01 | 2026-06-13 | 39.66 |
| 2026-05-01 | 2026-05-31 | 39.35 |
| 2026-04-29 | 2026-04-30 | 39.33 |
| 2026-04-01 | 2026-04-28 | 39.05 |
| 2026-03-27 | 2026-03-31 | 38.74 |
| 2026-03-20 | 2026-03-26 | 40.51 |
| 2026-03-02 | 2026-03-08 | 38.74 |
| 2026-02-03 | 2026-03-01 | 38.46 |
| 2026-01-27 | 2026-02-02 | 38.41 |
| 2026-01-11 | 2026-01-26 | 38.24 |
| 2026-01-08 | 2026-01-10 | 38.15 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.